These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23815775)

  • 41. Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.
    Peachman KK; Karasavvas N; Chenine AL; McLinden R; Rerks-Ngarm S; Jaranit K; Nitayaphan S; Pitisuttithum P; Tovanabutra S; Zolla-Pazner S; Michael NL; Kim JH; Alving CR; Rao M
    PLoS One; 2015; 10(12):e0143895. PubMed ID: 26625359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations.
    Huisman JG; Carotenuto A; Labrijn AF; Papavoine CH; Laman JD; Schellekens MM; Koppelman MH; Hilbers CW
    Biochemistry; 2000 Sep; 39(35):10866-76. PubMed ID: 10978173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120.
    Moulard M; Lortat-Jacob H; Mondor I; Roca G; Wyatt R; Sodroski J; Zhao L; Olson W; Kwong PD; Sattentau QJ
    J Virol; 2000 Feb; 74(4):1948-60. PubMed ID: 10644368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily.
    Bikker FJ; Ligtenberg AJ; Nazmi K; Veerman EC; van't Hof W; Bolscher JG; Poustka A; Nieuw Amerongen AV; Mollenhauer J
    J Biol Chem; 2002 Aug; 277(35):32109-15. PubMed ID: 12050164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.
    Schnur E; Noah E; Ayzenshtat I; Sargsyan H; Inui T; Ding FX; Arshava B; Sagi Y; Kessler N; Levy R; Scherf T; Naider F; Anglister J
    J Mol Biol; 2011 Jul; 410(5):778-97. PubMed ID: 21763489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region.
    Wyatt R; Thali M; Tilley S; Pinter A; Posner M; Ho D; Robinson J; Sodroski J
    J Virol; 1992 Dec; 66(12):6997-7004. PubMed ID: 1279195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is the V3 loop involved in HIV binding to CD4?
    Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
    Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A.
    Hochleitner EO; Gorny MK; Zolla-Pazner S; Tomer KB
    J Immunol; 2000 Apr; 164(8):4156-61. PubMed ID: 10754311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites.
    Pinter A; Honnen WJ; Tilley SA
    J Virol; 1993 Sep; 67(9):5692-7. PubMed ID: 7688827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop.
    Cook DG; Fantini J; Spitalnik SL; Gonzalez-Scarano F
    Virology; 1994 Jun; 201(2):206-14. PubMed ID: 8184533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.
    Andrianov AM; Veresov VG
    J Biomol Struct Dyn; 2007 Jun; 24(6):597-608. PubMed ID: 17508782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.
    Laman JD; Schellekens MM; Lewis GK; Moore JP; Matthews TJ; Langedijk JP; Meloen RH; Boersma WJ; Claassen E
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):605-12. PubMed ID: 8369165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
    Wu L; Gerard NP; Wyatt R; Choe H; Parolin C; Ruffing N; Borsetti A; Cardoso AA; Desjardin E; Newman W; Gerard C; Sodroski J
    Nature; 1996 Nov; 384(6605):179-83. PubMed ID: 8906795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120.
    Kuipers ME; Huisman JG; Swart PJ; de Béthune MP; Pauwels R; Schuitemaker H; De Clercq E; Meijer DK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):419-29. PubMed ID: 8605586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
    Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
    McCaffrey RA; Saunders C; Hensel M; Stamatatos L
    J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.
    Koch M; Pancera M; Kwong PD; Kolchinsky P; Grundner C; Wang L; Hendrickson WA; Sodroski J; Wyatt R
    Virology; 2003 Sep; 313(2):387-400. PubMed ID: 12954207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The N-terminal of the V3 loop in HIV type 1 gp120 is responsible for its conformation-dependent interaction with cell surface molecules.
    Ling H; Usami O; Xiao P; Gu HX; Hattori T
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):213-8. PubMed ID: 15018709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.